• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧盟/欧洲经济区国家急性医疗机构获得性肺炎:2011 年至 2012 年一项现况调查数据分析。

Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012.

机构信息

Unit of Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.

Surveillance and Response Support Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

出版信息

Euro Surveill. 2018 Aug;23(32). doi: 10.2807/1560-7917.ES.2018.23.32.1700843.

DOI:10.2807/1560-7917.ES.2018.23.32.1700843
PMID:30107871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6092912/
Abstract

An aim of the ECDC point prevalence survey (PPS) in European Union/European Economic Area acute care hospitals was to acquire standardised healthcare-associated infections (HAI) data. We analysed one of the most common HAIs in the ECDC PPS, healthcare-associated pneumonia (HAP). Standardised HAI case definitions were provided and countries were advised to recruit nationally representative subsets of hospitals. We calculated 95% confidence intervals (CIs) around prevalence estimates and adjusted for clustering at hospital level. Of 231,459 patients in the survey, 2,902 (1.3%; 95% CI: 1.2-1.3) fulfilled the case definition for a HAP. HAPs were most frequent in intensive care units (8.1%; 95% CI: 7.4-8.9) and among patients intubated on the day of the survey (15%; 95% CI: 14-17; n = 737 with HAP). The most frequently reported microorganism was (17% of 1,403 isolates), followed by us (12%) and spp. (12%). Antimicrobial resistance was common among isolated microorganisms. The most frequently prescribed antimicrobial group was penicillins, including combinations with beta-lactamase inhibitors. HAPs occur regularly among intubated and non-intubated patients, with marked differences between medical specialities. HAPs remain a priority for preventive interventions, including surveillance. Our data provide a reference for future prevalence of HAPs at various settings.

摘要

欧洲疾病预防控制中心(ECDC)在欧盟/欧洲经济区急性护理医院进行的现患率调查(PPS)旨在获取标准化的医疗保健相关感染(HAI)数据。我们分析了 ECDC PPS 中最常见的 HAI 之一——医院获得性肺炎(HAP)。提供了标准化的 HAI 病例定义,并建议各国招募具有代表性的医院子集。我们计算了流行率估计值的 95%置信区间(CI),并对医院层面的聚类进行了调整。在调查的 231,459 名患者中,有 2,902 名(1.3%;95%CI:1.2-1.3)符合 HAP 的病例定义。HAP 在重症监护病房(8.1%;95%CI:7.4-8.9)和调查当天插管的患者中最为常见(15%;95%CI:14-17;n=737 例有 HAP)。报告的最常见微生物是 (1,403 株分离株中 17%),其次是 (12%)和 spp.(12%)。分离微生物中普遍存在抗菌药物耐药性。最常开的抗菌药物组是青霉素类,包括与β-内酰胺酶抑制剂的组合。HAP 在插管和非插管患者中经常发生,不同医学专业之间存在显著差异。HAP 仍然是预防干预的重点,包括监测。我们的数据为不同环境下 HAP 的未来流行率提供了参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd3/6092912/544345128267/1700843-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd3/6092912/544345128267/1700843-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd3/6092912/544345128267/1700843-f1.jpg

相似文献

1
Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012.欧盟/欧洲经济区国家急性医疗机构获得性肺炎:2011 年至 2012 年一项现况调查数据分析。
Euro Surveill. 2018 Aug;23(32). doi: 10.2807/1560-7917.ES.2018.23.32.1700843.
2
Prevalence of health care-associated infections and antimicrobial resistance of the responsible pathogens in Ukraine: Results of a multicenter study (2014-2016).乌克兰医疗保健相关感染的流行情况和致病病原体的抗生素耐药性:一项多中心研究(2014-2016 年)的结果。
Am J Infect Control. 2019 Jun;47(6):e15-e20. doi: 10.1016/j.ajic.2019.03.007. Epub 2019 Apr 15.
3
Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey.新加坡急性护理医院成年住院患者的医源性感染和抗菌药物使用的流行率:来自首次全国时点患病率调查的结果。
Clin Infect Dis. 2017 May 15;64(suppl_2):S61-S67. doi: 10.1093/cid/cix103.
4
National point prevalence survey on healthcare-associated infections in acute care hospitals, Switzerland, 2017.2017 年瑞士急性医疗机构医疗保健相关性感染的全国现况调查。
Euro Surveill. 2019 Aug;24(32). doi: 10.2807/1560-7917.ES.2019.24.32.1800603.
5
Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017.比利时急性护理医院抗菌药物使用和与医疗保健相关感染的现况调查:2017 年全球现况调查和 ECDC 现况调查的结果。
Antimicrob Resist Infect Control. 2020 Jan 13;9(1):13. doi: 10.1186/s13756-019-0663-7. eCollection 2020.
6
Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.六种医疗保健相关感染对欧洲人群健康的负担:通过基于人群患病率的建模研究估算基于发病率的伤残调整生命年
PLoS Med. 2016 Oct 18;13(10):e1002150. doi: 10.1371/journal.pmed.1002150. eCollection 2016 Oct.
7
Prevalence and antibiotic sensitivity of Danish versus other European bacterial isolates from intensive care and hematology/oncology units.丹麦与其他欧洲国家来自重症监护病房及血液学/肿瘤学病房的细菌分离株的流行情况及抗生素敏感性
Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):275-81. doi: 10.1007/BF02116519.
8
The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.欧洲疾病预防控制中心(ECDC)的医疗保健相关性感染和抗菌药物使用试点现况调查。
Euro Surveill. 2012 Nov 15;17(46):20316. doi: 10.2807/ese.17.46.20316-en.
9
Healthcare-associated infections and antimicrobial use in acute care hospitals: a point prevalence survey in Lombardy, Italy, in 2022.2022 年意大利伦巴第地区急性保健医院的医疗保健相关性感染和抗菌药物使用:一项现况调查。
BMC Infect Dis. 2024 Jun 25;24(1):632. doi: 10.1186/s12879-024-09487-7.
10
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017.欧洲急性护理医院的抗菌药物使用情况:2016 至 2017 年针对与医疗保健相关感染和抗菌药物使用的第二次发病率调查(PPS)的结果。
Euro Surveill. 2018 Nov;23(46). doi: 10.2807/1560-7917.ES.23.46.1800393.

引用本文的文献

1
Clinical Characteristics and Prognosis of Patients with Severe Pneumonia with Neurological Dysfunction: A Regional Multicenter Retrospective Study in Mainland China.伴有神经功能障碍的重症肺炎患者的临床特征与预后:中国大陆一项区域性多中心回顾性研究
Infect Drug Resist. 2025 Aug 22;18:4215-4226. doi: 10.2147/IDR.S537406. eCollection 2025.
2
Considering local immunity for innovative immunomodulatory approaches: pulmonary sepsis as a use case.考虑用于创新免疫调节方法的局部免疫:以肺部脓毒症为例
Front Immunol. 2025 Aug 7;16:1627313. doi: 10.3389/fimmu.2025.1627313. eCollection 2025.
3
Water-Soluble Sulfur-Ylide-Functionalized Polyacrylamides for Antibacterial Surface Applications.

本文引用的文献

1
Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013.传染病对人口健康的影响,使用基于发病率的伤残调整生命年(DALYs):2009 至 2013 年欧洲传染病负担研究、欧盟和欧洲经济区国家的结果。
Euro Surveill. 2018 Apr;23(16). doi: 10.2807/1560-7917.ES.2018.23.16.17-00454.
2
Health-care-associated infections in neonates, children, and adolescents: an analysis of paediatric data from the European Centre for Disease Prevention and Control point-prevalence survey.医疗机构相关感染在新生儿、儿童和青少年中的情况:欧洲疾病预防控制中心进行的儿科数据点患病率调查分析。
Lancet Infect Dis. 2017 Apr;17(4):381-389. doi: 10.1016/S1473-3099(16)30517-5. Epub 2017 Jan 13.
3
用于抗菌表面应用的水溶性硫叶立德功能化聚丙烯酰胺
Langmuir. 2025 Apr 8;41(13):8627-8636. doi: 10.1021/acs.langmuir.4c05134. Epub 2025 Mar 24.
4
Microbial Colonization and Associated Factors in Indwelling Urinary Catheters: A Cross-Sectional Study.留置导尿管的微生物定植及相关因素:一项横断面研究。
Res Nurs Health. 2025 Jun;48(3):349-359. doi: 10.1002/nur.22454. Epub 2025 Feb 12.
5
Risk factors for nosocomial infection in patients undergoing extracorporeal membrane oxygenation support treatment: A systematic review and meta-analysis.体外膜肺氧合支持治疗患者医院感染的危险因素:系统评价和荟萃分析。
PLoS One. 2024 Nov 25;19(11):e0308078. doi: 10.1371/journal.pone.0308078. eCollection 2024.
6
Arthrospira maxima and biosynthesized zinc oxide nanoparticles as antibacterials against carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii: a review article.最大螺旋藻和生物合成氧化锌纳米粒子作为抗碳青霉烯类耐药肺炎克雷伯菌和鲍曼不动杆菌的抗菌剂:综述文章。
Microb Cell Fact. 2024 Nov 19;23(1):311. doi: 10.1186/s12934-024-02584-x.
7
A longitudinal point prevalence survey of antimicrobial use and resistance in tertiary care hospitals in Kerman: results from the national Iranian multicenter point prevalence survey of antimicrobials in 2021.2021 年伊朗全国多中心抗菌药物使用率和耐药性的横断面点 prevalence 调查:克尔曼三级保健医院抗菌药物使用和耐药性的纵向点 prevalence 调查结果。
BMC Infect Dis. 2024 Nov 14;24(1):1300. doi: 10.1186/s12879-024-10159-9.
8
Lipopolysaccharide as a Vaccine Target and the Role of Antibodies in Protection from Disease.脂多糖作为疫苗靶点及抗体在预防疾病中的作用。
Vaccines (Basel). 2024 Oct 17;12(10):1177. doi: 10.3390/vaccines12101177.
9
Preventability of Hospital Deaths in Patients With Non-Ventilator Hospital-Acquired Pneumonia.非呼吸机相关性医院获得性肺炎患者的医院死亡可预防性。
Clin Infect Dis. 2024 Nov 22;79(5):1269-1276. doi: 10.1093/cid/ciae418.
10
Novel Antibiotics for Gram-Negative Nosocomial Pneumonia.用于革兰氏阴性医院获得性肺炎的新型抗生素
Antibiotics (Basel). 2024 Jul 5;13(7):629. doi: 10.3390/antibiotics13070629.
Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.六种医疗保健相关感染对欧洲人群健康的负担:通过基于人群患病率的建模研究估算基于发病率的伤残调整生命年
PLoS Med. 2016 Oct 18;13(10):e1002150. doi: 10.1371/journal.pmed.1002150. eCollection 2016 Oct.
4
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.成人医院获得性肺炎和呼吸机相关性肺炎的管理:美国感染病学会和美国胸科学会2016年临床实践指南
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111. doi: 10.1093/cid/ciw353. Epub 2016 Jul 14.
5
Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys.通过连续的现患率调查评估加拿大医院中医院获得性感染的规模和趋势。
Antimicrob Resist Infect Control. 2016 May 21;5:19. doi: 10.1186/s13756-016-0118-3. eCollection 2016.
6
Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia.医院获得性肺炎治疗的当前及未来考量
Adv Ther. 2016 Feb;33(2):151-66. doi: 10.1007/s12325-016-0293-x. Epub 2016 Feb 9.
7
A national point prevalence study on healthcare-associated infections and antimicrobial use in Austria.奥地利医疗保健相关感染与抗菌药物使用的全国现况研究。
Wien Klin Wochenschr. 2016 Feb;128(3-4):89-94. doi: 10.1007/s00508-015-0947-8. Epub 2016 Jan 27.
8
Economic Evaluation of Interventions for Prevention of Hospital Acquired Infections: A Systematic Review.预防医院获得性感染干预措施的经济学评价:系统综述
PLoS One. 2016 Jan 5;11(1):e0146381. doi: 10.1371/journal.pone.0146381. eCollection 2016.
9
[A point prevalence survey of healthcare-associated infections in the Slovak Republic - a part of the EU project].[斯洛伐克共和国医疗保健相关感染现况调查——欧盟项目的一部分]
Epidemiol Mikrobiol Imunol. 2014 Jun;63(2):107-12.
10
Assessing the burden of healthcare-associated infections through prevalence studies: what is the best method?通过现况研究评估医疗保健相关感染的负担:最佳方法是什么?
Infect Control Hosp Epidemiol. 2014 Jun;35(6):674-84. doi: 10.1086/676424. Epub 2014 Apr 17.